approval
saveBUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval
May 3, 2022updated 5mo ago
community read0 votes
Sponsor: TEVA PHARMS USA. Form: TABLET. Route: SUBLINGUAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
same company · ±60 days · 6
- approvalPOMALIDOMIDE — FDA approvalMay 4, 2022
- approvalNIZORAL ANTI-DANDRUFF (KETOCONAZOLE) — FDA approvalMay 13, 2022
- approvalOXALIPLATIN — FDA approvalMar 31, 2022
- approvalFINASTERIDE — FDA approvalJun 7, 2022
- approvalFINASTERIDE — FDA approvalJun 7, 2022
- approvalBUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approvalJun 13, 2022
🐶 often sniffed alongside
top 8- tagRecall26 co-mentions · 19 sources
- tagDrug Shortage9 co-mentions · 9 sources
- drugprazosin hydrochloride6 co-mentions · 3 sources
- drugISOTRETINOIN4 co-mentions · 2 sources
- drugAbsorica4 co-mentions · 2 sources
- drugmetoprolol succinate SR4 co-mentions · 4 sources
- drugmetoprolol succinate ER4 co-mentions · 4 sources
- drugZENATANE4 co-mentions · 2 sources
comments(0)
5-min edit window · permanent after that